POLICY BRIEFINGS


Recently Introduced Health Legislation


H.Res.95 — Expressing support for designation of February 4, 2019, as National Cancer Prevention Day; Sponsor: Rep. Dingell, Debbie [D-MI-12]; Committees: House - Energy and Commerce

H.R.955 — To improve the reproductive assistance provided by the Department of Defense and the Department of Veterans Affairs to severely wounded, ill, or injured members of the Armed Forces, veterans, and their spouses or partners, and for other purposes; Sponsor: Rep. Larsen, Rick [D-WA-2]; Committees: House - Veterans’ Affairs, Armed Services

S.317 — A bill to amend title XIX of the Social Security Act to provide States with the option of providing coordinated care for children with complex medical conditions through a health home; Sponsor: Sen. Grassley, Chuck [R-IA]; Committees: Senate – Finance

S.318 — A bill to authorize the Secretary of Veterans Affairs to furnish medically necessary transportation for newborn children of certain women veterans; Sponsor: Sen. Murray, Patty [D-WA]; Committees: Senate - Veterans’ Affairs

S.319 — A bill to improve the reproductive assistance provided by the Department of Defense and the Department of Veterans Affairs to severely wounded, ill, or injured members of the Armed Forces, veterans, and their spouses or partners, and for other purposes; Sponsor: Sen. Murray, Patty [D-WA]; Committees: Senate - Veterans’ Affairs

S.340 — A bill to promote competition in the market for drugs and biological products by facilitating the timely entry of lower-cost generic and biosimilar versions of those drugs and biological products; Sponsor: Sen. Leahy, Patrick J. [DVT]; Placed on Senate Legislative Calendar under Read the First Time.

H.R.962 — To amend title 18, United States Code, to prohibit a health care practitioner from failing to exercise the proper degree of care in the case of a child who survives an abortion or attempted abortion; Sponsor: Rep. Wagner, Ann [R-MO-2]; Committees: House – Judiciary

H.R.965 — To promote competition in the market for drugs and biological products by facilitating the timely entry of lower-cost generic and biosimilar versions of those drugs and biological products; Sponsor: Rep. Cicilline, David N. [DRI- 1]; Committees: House - Energy and Commerce, Judiciary

H.R.973 — To amend the Public Health Service Act to provide for additional programs funded by grants to strengthen the healthcare system’s response to domestic violence, dating violence, sexual assault, and stalking, and for other purposes; Sponsor: Rep. Dingell, Debbie [D-MI-12]; Committees: House - Energy and Commerce

H.R.985 — To amend the Federal Food, Drug, and Cosmetic Act to ensure that eligible product developers have competitive access to approved drugs and licensed biological products, so as to enable eligible product developers to develop and test new products, and for other purposes; Sponsor: Rep. Welch, Peter [D-VT-At Large]; Committees: House - Energy and Commerce

H.J.Res.43 — Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the final rule of the Department of the Treasury, the Department of Labor, and the Department of Health and Human Services relating to “Short-Term, Limited-Duration Insurance”; Sponsor: Rep. Castor, Kathy [D-FL-14]; Committees: House - Energy and Commerce, Education and Labor, Ways and Means

H.R.986 — To provide that certain guidance related to waivers for State innovation under the Patient Protection and Affordable Care Act shall have no force or effect; Sponsor: Rep. Kuster, Ann M. [D-NH-2]; Committees: House - Energy and Commerce, Ways and Means

H.R.987 — To amend the Patient Protection and Affordable Care Act to provide for Federal Exchange outreach and educational activities; Sponsor: Rep. Blunt Rochester, Lisa [D-DE-At Large]; Committees: House - Energy and Commerce, Budget

H.R.990 — To amend the Federal Food, Drug, and Cosmetic Act and the Securities Exchange Act of 1934 to prevent the inter partes review process for challenging patents from diminishing competition in the pharmaceutical industry and with respect to drug innovation, and for other purposes; Sponsor: Rep. Flores, Bill [R-TX-17]; Committees: House - Energy and Commerce, Financial Services

H.R.996 — To amend the Internal Revenue Code of 1986 to exclude from gross income certain federally-subsidized loan repayments for dental school faculty; Sponsor: Rep. Clarke, Yvette D. [D-NY-9]; Committees: House - Ways and Means, Energy and Commerce

H.R.1005 — To direct the Secretary of Veterans Affairs to amend the schedule for rating disabilities to add a diagnostic code and evaluation criteria for obliterative bronchiolitis, and for other purposes; Sponsor: Rep. Castro, Joaquin [D-TX- 20]; Committees: House - Veterans’ Affairs

H.R.1010 — To provide that the rule entitled “Short-Term, Limited Duration Insurance” shall have no force or effect; Sponsor: Rep. Castor, Kathy [D-FL-14]; Committees: House - Energy and Commerce, Education and Labor, Ways and Means

S.344 — A bill to amend the Federal Food, Drug, and Cosmetic Act and the Securities Exchange Act of 1934 to prevent the inter partes review process for challenging patents from diminishing competition in the pharmaceutical industry and with respect to drug innovation, and for other purposes; Sponsor: Sen. Tillis, Thom [R-NC]; Committees: Senate - Health, Education, Labor, and Pensions

S.348 — A bill to amend title XVIII of the Social Security Act to provide for the distribution of additional residency positions, and for other purposes; Sponsor: Sen. Menendez, Robert [D-NJ]; Committees: Senate – Finance

S.350 — A bill to restore the application of the Federal antitrust laws to the business of health insurance to protect competition and consumers; Sponsor: Sen. Daines, Steve [R-MT]; Committees: Senate – Judiciary



February 11, 2019: | Page 1 Page 2 Page 3 Page 4 Page 5

SERVICES




BRIEFING ARCHIVE


 -  2021


 +  2020


 +  2019


 +  2018